Cara Therapeutics, Inc. (0HTC.L)

USD 4.52

(-9.57%)

Inventory Summary of Cara Therapeutics, Inc.

  • Cara Therapeutics, Inc.'s latest annual inventory in 2023 was 2.82 Million USD , up 18.38% from previous year.
  • Cara Therapeutics, Inc.'s latest quarterly inventory in 2024 Q2 was 1.64 Million USD , down -40.02% from previous quarter.
  • Cara Therapeutics, Inc. reported annual inventory of 2.38 Million USD in 2022, down -7.78% from previous year.
  • Cara Therapeutics, Inc. reported annual inventory of 2.58 Million USD in 2021, up 271.47% from previous year.
  • Cara Therapeutics, Inc. reported quarterly inventory of 1.64 Million USD for 2024 Q2, down -40.02% from previous quarter.
  • Cara Therapeutics, Inc. reported quarterly inventory of 2.82 Million USD for 2023 FY, up 18.38% from previous quarter.

Annual Inventory Chart of Cara Therapeutics, Inc. (2023 - 2011)

Historical Annual Inventory of Cara Therapeutics, Inc. (2023 - 2011)

Year Inventory Inventory Growth
2023 2.82 Million USD 18.38%
2022 2.38 Million USD -7.78%
2021 2.58 Million USD 271.47%
2020 -1.5 Million USD -84.68%
2019 -816 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 34 Thousand USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Inventory Comparison of Cara Therapeutics, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD 76.539%
Agios Pharmaceuticals, Inc. 19.07 Million USD 85.212%
Amicus Therapeutics, Inc. 59.69 Million USD 95.274%
Atara Biotherapeutics, Inc. 9.7 Million USD 70.936%
bluebird bio, Inc. 22.91 Million USD 87.691%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 99.269%
Myriad Genetics, Inc. 20.1 Million USD 85.965%
Neurocrine Biosciences, Inc. 38.3 Million USD 92.634%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 96.356%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.966%
Waters Corporation 516.23 Million USD 99.454%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.945%
Biogen Inc. 2.52 Billion USD 99.888%
Nektar Therapeutics 16.1 Million USD 82.479%
Perrigo Company plc 1.14 Billion USD 99.753%
Dynavax Technologies Corporation 53.29 Million USD 94.706%
Illumina, Inc. 587 Million USD 99.519%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD 72.802%
Heron Therapeutics, Inc. 42.11 Million USD 93.301%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 99.745%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD 74.35%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.891%
Esperion Therapeutics, Inc. 65.62 Million USD 95.701%
FibroGen, Inc. 41.56 Million USD 93.213%
Agilent Technologies, Inc. 1.03 Billion USD 99.726%
OPKO Health, Inc. 65.69 Million USD 95.706%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 96.836%
Exelixis, Inc. 17.32 Million USD 83.715%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.89%
Axsome Therapeutics, Inc. 15.13 Million USD 81.361%
Abeona Therapeutics Inc. -2.44 Million USD 215.426%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 99.618%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 90.076%
Sarepta Therapeutics, Inc. 322.85 Million USD 99.126%
Corcept Therapeutics Incorporated 7.73 Million USD 63.506%
Halozyme Therapeutics, Inc. 127.6 Million USD 97.789%
Blueprint Medicines Corporation 21.22 Million USD 86.708%
Insmed Incorporated 83.24 Million USD 96.611%
TG Therapeutics, Inc. 39.82 Million USD 92.916%
Incyte Corporation 62.97 Million USD 95.52%
Emergent BioSolutions Inc. 328.9 Million USD 99.142%